Overview

Gold Sodium Thiomalate in Treating Patients With Advanced Non-Small Cell Lung Cancer

Status:
Completed
Trial end date:
2012-02-14
Target enrollment:
Participant gender:
Summary
RATIONALE: Gold sodium thiomalate may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. PURPOSE: This phase I trial is studying the side effects and best dose of gold sodium thiomalate in treating patients with advanced non-small cell lung cancer.
Phase:
Phase 1
Details
Lead Sponsor:
Mayo Clinic
Treatments:
Gold Sodium Thiomalate